Driving Medical Innovation Empowering Global Growth
Driving Medical Innovation Empowering Global Growth
China Pharmaceutical and Medical Device Enterprise Overseas Platform
China Pharmaceutical and Medical Device Enterprise Overseas Platform
Shinying Medical Global Official Website
Shinying Medical Global Official Website
Accelerating health enterprises with professional CRO services and global channel solutions.
Accelerating health enterprises with professional CRO services and global channel solutions.
Provides full-process registration consulting services for medical devices and pharmaceuticals, as well as overseas market launch solutions.
Shinying Introduction · Video Section
Empowering the healthcare industry to go global, leading the globalization of China's healthcare industry.
Shinying Med Company Profile
Shinying Med Company Profile
Shinying Med Global was officially established in August 2023 in Shanghai, China, with the core mission of driving medical innovation and empowering global growth, focusing on providing professional support for Chinese pharmaceutical and medical device companies going abroad. We integrate three core advantages to help companies efficiently expand into global markets:
1. Professional Clinical Research (CRO) services, laying a solid foundation for compliant market entry of pharmaceuticals and medical devices;
2. Global commercial channel solutions, facilitating access and implementation paths in overseas markets;
3. Comprehensive import and export services for pharmaceuticals and medical devices, along with a strong distribution network, achieving efficient connections between production and sales.
Leveraging multidimensional collaborative efforts, we accelerate the product launch process for medical enterprises and broaden the global market landscape through a "dual-driven + import and export implementation" model. With our professional capabilities and resource advantages, we aim to become a reliable strategic partner for Chinese pharmaceutical and medical device companies venturing abroad, helping them achieve high-quality growth in the global pharmaceutical and health industry wave.
As a strategic growth partner for medical enterprises, we have built a full-chain service system of "product compliance + business planning + import and export implementation," covering the pharmaceutical and medical device fields in China and overseas comprehensively. On the product side, we have developed a comprehensive CRO service system that strictly adheres to international regulatory standards, laying a solid foundation for compliant product market entry and helping companies overcome barriers to overseas market access; on the commercial side, we have not only established a global sales network that covers core markets in China, Southeast Asia, the Middle East, Japan and South Korea, Brazil, and Australia, but also deeply engaged in the global import and export business of pharmaceuticals and medical devices, possessing complete import and export qualifications and professional operational capabilities, providing standardized services throughout the entire process from customs declaration, inspection, logistics and warehousing to customs clearance and delivery, efficiently connecting the global production and sales ends.
Shinying Med Global was officially established in August 2023 in Shanghai, China, with the core mission of driving medical innovation and empowering global growth, focusing on providing professional support for Chinese pharmaceutical and medical device companies going abroad. We integrate three core advantages to help companies efficiently expand into global markets:
1. Professional Clinical Research (CRO) services, laying a solid foundation for compliant market entry of pharmaceuticals and medical devices;
2. Global commercial channel solutions, facilitating access and implementation paths in overseas markets;
3. Comprehensive import and export services for pharmaceuticals and medical devices, along with a strong distribution network, achieving efficient connections between production and sales.
Leveraging multidimensional collaborative efforts, we accelerate the product launch process for medical enterprises and broaden the global market landscape through a "dual-driven + import and export implementation" model. With our professional capabilities and resource advantages, we aim to become a reliable strategic partner for Chinese pharmaceutical and medical device companies venturing abroad, helping them achieve high-quality growth in the global pharmaceutical and health industry wave.
As a strategic growth partner for medical enterprises, we have built a full-chain service system of "product compliance + business planning + import and export implementation," covering the pharmaceutical and medical device fields in China and overseas comprehensively. On the product side, we have developed a comprehensive CRO service system that strictly adheres to international regulatory standards, laying a solid foundation for compliant product market entry and helping companies overcome barriers to overseas market access; on the commercial side, we have not only established a global sales network that covers core markets in China, Southeast Asia, the Middle East, Japan and South Korea, Brazil, and Australia, but also deeply engaged in the global import and export business of pharmaceuticals and medical devices, possessing complete import and export qualifications and professional operational capabilities, providing standardized services throughout the entire process from customs declaration, inspection, logistics and warehousing to customs clearance and delivery, efficiently connecting the global production and sales ends.
Overseas Market Sales Channels
Overseas Market Sales Channels
United States
United States
Brazil
Brazil
Turkey
Turkey
Saudi Arabia
Saudi Arabia
UAE
UAE
Japan
Japan
South Korea
South Korea
Malaysia
Malaysia
Singapore
Singapore
Indonesia
Indonesia
Australia
Australia
Globalization Strategic Layout: Overseas Market Expansion Plan
United States, Brazil Market
United States, Brazil: IVD sales, innovative drug sales platform.
Southeast Asia
Malaysia, Indonesia, Singapore: National drug/device sales channels, registration, and enterprise localization.
Middle East
Saudi Arabia, UAE, Turkey:
Product export, hospital sales channels.
Our Advantages
Our Advantages
Exclusive Green Channel
Priority Approval Service for Drug and Medical Device Registration
Exclusive Green Channel
Priority Approval Service for Drug and Medical Device Registration
Leveraging deep cooperation with departments such as the Malaysian National Pharmaceutical Regulatory Agency (NPRA), we provide registration consulting and priority approval agency services for enterprises. For urgently needed local drugs, rare disease drugs, anti-cancer drugs, first generic drugs, innovative products for key clinical trials, and products with high local demand, we assist in matching priority approval standards, optimizing processes, and significantly shortening the cycle. For medical devices, we provide customized solutions based on risk classes A/B/C/D, completing classification, pilot programs in benchmark hospitals, conformity assessment, and material submission, ensuring efficiency and compliance.
For Chinese drugs going overseas, certification is a key challenge. Currently, China is not a PIC/S member, and registering Chinese drug approvals overseas can take 2-3 years. Proactively planning the certification path is superior to passively responding. Obtaining PIC/S GMP certification issued by Malaysia's NPRA is an efficient strategy that can significantly enhance the convenience of Chinese drugs entering the markets of other PIC/S member countries. As a PIC/S member country, Malaysia's GMP certification can achieve mutual recognition in multiple countries, possessing the value of "one certificate for multiple countries."
Leveraging deep cooperation with departments such as the Malaysian National Pharmaceutical Regulatory Agency (NPRA), we provide registration consulting and priority approval agency services for enterprises. For urgently needed local drugs, rare disease drugs, anti-cancer drugs, first generic drugs, innovative products for key clinical trials, and products with high local demand, we assist in matching priority approval standards, optimizing processes, and significantly shortening the cycle. For medical devices, we provide customized solutions based on risk classes A/B/C/D, completing classification, pilot programs in benchmark hospitals, conformity assessment, and material submission, ensuring efficiency and compliance.
For Chinese drugs going overseas, certification is a key challenge. Currently, China is not a PIC/S member, and registering Chinese drug approvals overseas can take 2-3 years. Proactively planning the certification path is superior to passively responding. Obtaining PIC/S GMP certification issued by Malaysia's NPRA is an efficient strategy that can significantly enhance the convenience of Chinese drugs entering the markets of other PIC/S member countries. As a PIC/S member country, Malaysia's GMP certification can achieve mutual recognition in multiple countries, possessing the value of "one certificate for multiple countries."
In-depth Market Research
Accurate insights into industry dynamics and competitive landscape
In-depth Market Research
Accurate insights into industry dynamics and competitive landscape
Leveraging our professional research team and in-depth localized data network, we provide clients with comprehensive research services for the Malaysian pharmaceutical and medical device market. This covers key data and in-depth analysis of annual sales, segmented category development trends, and core competitive landscape.
Service content includes: systematically outlining the business strategies, product strategies, and market share of multinational corporations and leading local enterprises; in-depth analysis of market demand, technological iteration, and development trends in core segments such as chronic disease drugs, anti-tumor drugs, medical consumables, and diagnostic imaging equipment; and providing continuous updates on market dynamics throughout the year, promptly tracking changes in policies and regulations, industry regulatory trends, and the evolution of the competitive landscape.
Through precise and reliable localized insights, we assist enterprises in clearly defining product direction, scientifically formulating pricing strategies, efficiently deploying in the Malaysian pharmaceutical and medical device market, and enhancing market decision-making efficiency and competitive advantage.
Leveraging our professional research team and in-depth localized data network, we provide clients with comprehensive research services for the Malaysian pharmaceutical and medical device market. This covers key data and in-depth analysis of annual sales, segmented category development trends, and core competitive landscape.
Service content includes: systematically outlining the business strategies, product strategies, and market share of multinational corporations and leading local enterprises; in-depth analysis of market demand, technological iteration, and development trends in core segments such as chronic disease drugs, anti-tumor drugs, medical consumables, and diagnostic imaging equipment; and providing continuous updates on market dynamics throughout the year, promptly tracking changes in policies and regulations, industry regulatory trends, and the evolution of the competitive landscape.
Through precise and reliable localized insights, we assist enterprises in clearly defining product direction, scientifically formulating pricing strategies, efficiently deploying in the Malaysian pharmaceutical and medical device market, and enhancing market decision-making efficiency and competitive advantage.
Customized Market Entry Strategy
Achieve Precise Implementation and Efficient Growth
Customized Market Entry Strategy
Achieve Precise Implementation and Efficient Growth
Based on in-depth research findings, we tailor a one-stop market access and implementation strategy for the Malaysian pharmaceutical and medical device market for enterprises. This strategy precisely matches product characteristics with local market demands, efficiently unlocking the entire commercialization value chain.
In terms of channel development, we assist enterprises in quickly connecting with mainstream pharmaceutical distributors, public and private healthcare institutions in Malaysia, and integrate high-quality medical tourism resources to build a stable and efficient localized sales network. We also provide comprehensive product localization support, including bilingual label production, Halal certification guidance, and other compliance services, to ensure products comply with local regulations and cultural customs, thereby reducing market access risks.
Furthermore, we will leverage local industry resources to assist enterprises in participating in authoritative medical industry exhibitions and high-level academic exchange activities, strengthening brand exposure and professional endorsement, enhancing market recognition, and helping enterprises achieve synchronized growth in brand influence and sales performance.
Based on in-depth research findings, we tailor a one-stop market access and implementation strategy for the Malaysian pharmaceutical and medical device market for enterprises. This strategy precisely matches product characteristics with local market demands, efficiently unlocking the entire commercialization value chain.
In terms of channel development, we assist enterprises in quickly connecting with mainstream pharmaceutical distributors, public and private healthcare institutions in Malaysia, and integrate high-quality medical tourism resources to build a stable and efficient localized sales network. We also provide comprehensive product localization support, including bilingual label production, Halal certification guidance, and other compliance services, to ensure products comply with local regulations and cultural customs, thereby reducing market access risks.
Furthermore, we will leverage local industry resources to assist enterprises in participating in authoritative medical industry exhibitions and high-level academic exchange activities, strengthening brand exposure and professional endorsement, enhancing market recognition, and helping enterprises achieve synchronized growth in brand influence and sales performance.
Copyright © 2026, Shinying Med. All Rights Reserved.
Copyright © 2026, Shinying Med. All Rights Reserved.